Navigation Links
StemCyte Adds World Class Talent to its North America and Global Operations
Date:12/13/2011

he following individuals to join its team:

Dr David Senitzer, PhD, a leading laboratory and technology expert, will be StemCyte's new Laboratory Director responsible for all UCB and HLA laboratory operations.  Senitzer has been the Clinical Professor of Hematology and Hematopoietic Stem Cell Transplantation and Director of the Histocompatibility Laboratory at The City of Hope National Cancer Center since 1994.  He will oversee StemCyte's unique dual processing capabilities ensuring that its laboratory operations comply with all current and anticipated regulatory protocols.

Dr. Jennifer Willert, MD will join StemCyte as a Medical Officer.  Dr. Willert is an Associate Clinical Professor, University of California-San Diego School of Medicine. She specializes in blood and marrow transplant with the Division of hematology/oncology/BMT. She has prescribed and used cord blood units for treatment of critically ill children and supports broader accessibility of these life-saving resources to patients in need. Dr. Willert has a strong interest in stem cell research and regenerative medicine, along with emerging clinical applications using UCB.

Dr. Karen Taylor, MD, a Board Certified Obstetrician has joined StemCyte to oversee its collection methods, as well as its education programming for expecting parents, doctors and other health professionals engaged in the collection, documentation and chain of custody of UCB units. 

"We are pleased to be adding Doctors Jen Willert, Karen Taylor and David Senitzer to oversee our transplant, collection and lab-processing activities," said Giacin.  "These outstanding people will enhance StemCyte's unique hybrid business model in the cord blood industry.  We could not be happier to have such passionate, committed and expert personnel added to our team. Their caliber demonstrates our deep and continued commitment to providing life-sa
'/>"/>

SOURCE StemCyte, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. StemCyte Launches New Website
2. StemCyte Awarded $488,950 for Advanced Therapeutic Applications of Umbilical Cord Blood Stem Cells from the Qualifying Therapeutic Discovery Project (QTDP)
3. 7-Time Olympic Medalist Shannon Miller Endorses StemCyte
4. The worlds smallest steam engine
5. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Researchers develop one of the worlds smallest electronic circuits
8. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
9. Multidisciplinary team of researchers develop world’s lightest material
10. Researching graphene nanoelectronics for a post-silicon world
11. Plasma etching pushes the limits of a shrinking world
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)...  Multiple new research abstracts suggest walnuts may have ... From their impact on colon cancer and certain aspects ... gut health and vascular health, the research findings presented ... of walnuts, inner workings. Running March 28 through April ... meeting attracts an international audience of over 14,000 leading ...
(Date:3/30/2015)... -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ: ... Yale University, on March 27 released pre-clinical data on ... an oral presentation by Professor Gil Mor ... nd Annual Scientific Meeting of the Society of ... In both in vitro and in ...
(Date:3/30/2015)... , March 30, 2015  Spherix Incorporated ... committed to the fostering and monetization of intellectual ... VTech,  Case No. 3:13-cv-03494-M and  Spherix v. Uniden ... States District Court for the Northern District of ... regarding Spherix v. Verizon, Case No. ...
(Date:3/30/2015)... -- Richmond Pharmacology nimmt weltweit den ... das erste Zentrum weltweit, das in Zusammenarbeit mit ... London in einer weltweiten ... einem Patienten begonnen hat. Das Therapeutikum wurde für ... einer seltenen Herz- und Nervenkrankheit. ...
Breaking Biology Technology:New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4Yale University and Novogen Release Data on Cantrixil Mode of Action 2Yale University and Novogen Release Data on Cantrixil Mode of Action 3Yale University and Novogen Release Data on Cantrixil Mode of Action 4Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
... and Company,(NYSE: LLY ) announced today that its ... for all outstanding,shares of ImClone Systems Incorporated (Nasdaq: ... in cash. Lilly and ImClone previously announced that they ... ImClone., The Board of Directors of ImClone has ...
... NLTX ), today announced interim data from its multi-center,open-label Phase ... patients hospitalized for acute heart failure., -- ... pressure -- Statistically significant increase in ... pressure -- Trend toward increase in cardiac output ...
... release date, NATICK, Mass., Oct. 14 ... the following comments reinforcing,the strength of its balance ... and the Company,s stock price,volatility have had no ... performance of the Company. Strong cash flow generation,during ...
Cached Biology Technology:Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share 2Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share 3Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 2Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 3Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 4Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure 5Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet 2Boston Scientific Provides Comments Reinforcing Strength of Its Balance Sheet 3
(Date:3/24/2015)... --  NexID Biometrics LLC, whose spoof-mitigation technology boosts ... the beginning of shipments of version 2.0 of its ... based in Potsdam, N.Y. , is ... began here today at the Walter E. Washington Convention ... SDK boosts the accuracy rate range to 96.5 to ...
(Date:3/23/2015)... SoundView Technology Group issues a new research update ... Wocket smart wallet. SoundView was one of the selected user groups ... the Wocket in multiple scenarios and outlets. ... retailers, making both debit and credit card payments.  ... the company meets their plans in 2015, it would push ...
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3
... Technology has awarded almost $100,000 as part of its ... in NJIT,s high technology business incubator. Applechem ... located in NJIT,s Enterprise Development Center (EDC), each received ... Center works hard to help young inventors wend their ...
... CHAMPAIGN, Ill. Women taking aromatase inhibitors to treat ... before also taking a soy-based dietary supplement, researchers report. ... of estrogen in the body, can negate the effectiveness ... levels of estrogens that can promote tumor growth in ...
... colleagues have completed the genome sequence and genetic map ... plant parasites - Meloidogyne hapla , a microscopic, ... nematode. The research could help lead to a ... parasitic worm, which, along with other species of root-knot ...
Cached Biology News:Exciting new companies at NJIT's small biz incubator get 100K in grants 2The dietary supplement genistein can undermine breast cancer treatment 2The dietary supplement genistein can undermine breast cancer treatment 3NC State researchers get to root of parasite genome 2NC State researchers get to root of parasite genome 3
Autoclavable, variable volumefitted w./ an anti-drip safety valve; borosilicate glass barrelprotected with transparentpolypropylene sleeve; spring-lock cursor design ensuresfine adjustment for exact ...
Spaced cover glasses to promote effective hybridization...
Disposable tips with floating filter (US Patent 6,702,990) for PDM1.5 OneTouch Plus spotpicker, 10 racks of 96, DNAse and RNAse free...
... new D-LUX Detection Platform combines robust ... the most sensitive, specific, and cost-effective ... D-LUX Detection Platform offers exceptional performance ... TaqMan probes, high signal/background ratio, and ...
Biology Products: